NO950291L - Farmasöytisk preparat for topisk anvendelse inneholdende en tverrbundet kationisk polymer og en alkoksylert eter - Google Patents

Farmasöytisk preparat for topisk anvendelse inneholdende en tverrbundet kationisk polymer og en alkoksylert eter

Info

Publication number
NO950291L
NO950291L NO950291A NO950291A NO950291L NO 950291 L NO950291 L NO 950291L NO 950291 A NO950291 A NO 950291A NO 950291 A NO950291 A NO 950291A NO 950291 L NO950291 L NO 950291L
Authority
NO
Norway
Prior art keywords
cationic polymer
topical application
cross
pharmaceutical preparation
alkoxylated ether
Prior art date
Application number
NO950291A
Other languages
English (en)
Other versions
NO950291D0 (no
Inventor
Roberta Christine Bloom
George Endel Deckner
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO950291D0 publication Critical patent/NO950291D0/no
Publication of NO950291L publication Critical patent/NO950291L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører farmasøytiske preparater for topisk på-føring omfattende en sikker og effektiv mengde av en farma-søytisk aktiv substans, fra omtrent 0,1 % til omtrent 10,0 % av en kationisk polymer med høy molekylvekt, fra omtrent 0,0B % til omtrent 5 % av en ikke-ionisk surfaktant med høy HLB, og fra omtrent 0,1 % til omtrent 25 % av en alkoksylert eter. I ytterligere utførelsesformer omfatter disse preparater også fra omtrent 0,01 % til omtrent 5 % av en ikke-toksisk surfaktant med lav HLB.
NO950291A 1992-07-28 1995-01-26 Farmasöytisk preparat for topisk anvendelse inneholdende en tverrbundet kationisk polymer og en alkoksylert eter NO950291L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92093792A 1992-07-28 1992-07-28
US95052792A 1992-09-25 1992-09-25
US3321193A 1993-03-18 1993-03-18
US7997793A 1993-06-25 1993-06-25
PCT/US1993/006542 WO1994002176A1 (en) 1992-07-28 1993-07-12 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether

Publications (2)

Publication Number Publication Date
NO950291D0 NO950291D0 (no) 1995-01-26
NO950291L true NO950291L (no) 1995-03-27

Family

ID=27488097

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950291A NO950291L (no) 1992-07-28 1995-01-26 Farmasöytisk preparat for topisk anvendelse inneholdende en tverrbundet kationisk polymer og en alkoksylert eter

Country Status (15)

Country Link
US (1) US5614178A (no)
EP (1) EP0652774B1 (no)
JP (1) JP3567990B2 (no)
KR (1) KR950702436A (no)
CN (1) CN1072965C (no)
AT (1) ATE152630T1 (no)
AU (1) AU4673993A (no)
BR (1) BR9306816A (no)
CA (1) CA2141192C (no)
DE (1) DE69310518T2 (no)
ES (1) ES2101330T3 (no)
FI (1) FI950368L (no)
MX (1) MX9304530A (no)
NO (1) NO950291L (no)
WO (1) WO1994002176A1 (no)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2114569T3 (es) * 1991-10-16 1998-06-01 Richardson Vicks Inc Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
FR2702653B1 (fr) * 1993-03-16 1995-05-24 Oreal Utilisation en cosmétique ou en application topique d'une dispersion aqueuse à base d'organopolysiloxanes non volatils et d'un polymère réticulé de chlorure de méthacryloyloxyéthyl triméthylammonium .
CA2168543A1 (en) * 1993-07-03 1995-02-09 George Endel Deckner Personal cleansing compositions
US5989536A (en) * 1993-07-03 1999-11-23 The Procter & Gamble Company Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin
WO1995022311A1 (en) † 1994-02-18 1995-08-24 Unilever Plc Personal washing compositions
EP0748203A1 (en) * 1994-03-11 1996-12-18 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5948416A (en) * 1995-06-29 1999-09-07 The Procter & Gamble Company Stable topical compositions
DE19603018C2 (de) * 1996-01-17 1998-02-26 Lancaster Group Gmbh Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers
US6093408A (en) * 1996-10-25 2000-07-25 The Procter & Gamble Company Skin care compositions
US5916543A (en) * 1996-12-18 1999-06-29 Schering-Plough Healthcare Products, Inc. Emulsions having minimal rub-in times
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
US20050058709A1 (en) * 1997-06-04 2005-03-17 Fisher Gary J. Methods for inhibiting photoaging of human skin using orally-administered agent
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
EP0884045A1 (en) 1997-06-06 1998-12-16 Pfizer Products Inc. Self-tanning dihydroxyacetone formulations having improved stability and providing enhanced delivery
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
JP4672140B2 (ja) 1998-03-12 2011-04-20 ザ プロクター アンド ギャンブル カンパニー 酵素インヒビターを含有するスキンケア組成物を有する使い捨て吸収性製品
KR100464601B1 (ko) * 1998-10-23 2004-12-31 이데아 악티엔게젤샤프트 페이로드를 증가시키고, 분리/결합율을 제어하기 위한 거대 분자 결합체 및 복합응집체의 생장, 시험 및 사용방법
FR2785803B1 (fr) * 1998-11-17 2005-03-25 Sanofi Sa Utilisation d'une substance se liant au recepteur peripherique des benzodiazepines dans le traitement des stress cutanes
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
US20050191337A1 (en) * 1999-03-31 2005-09-01 L'oreal S.A. Patch with a magnetic field effect
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
US6849252B1 (en) * 1999-09-03 2005-02-01 The Procter & Gamble Company Hair care composition comprising a polypropylene glycol
WO2001043717A1 (en) * 1999-12-17 2001-06-21 The Procter & Gamble Company Compositions for efficient release of active ingredients
JP4653282B2 (ja) * 2000-05-23 2011-03-16 昭和薬品化工株式会社 ミノサイクリン含有組成物
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
GB0029198D0 (en) * 2000-11-30 2001-01-17 Ciba Sc Holding Ag Liquid dispersion polymer compositions their preparation and their use
US6869618B2 (en) * 2001-04-10 2005-03-22 Kiel Laboratories, Inc. Process for preparing tannate liquid and semi-solid dosage forms
US7273623B2 (en) 2001-10-12 2007-09-25 Kiel Laboratories, Inc. Process for preparing tannate tablet, capsule or other solid dosage forms
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2447302C (en) * 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
RU2276998C2 (ru) * 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6509492B1 (en) 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6830746B2 (en) 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions
AU2003217703A1 (en) * 2002-04-09 2003-10-27 Kiel Laboratories, Inc Diphenhydramine tannate solid dose compositions and methods of use
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
KR100469995B1 (ko) * 2002-05-20 2005-02-05 안국약품 주식회사 천식치료제를 함유한 매트릭스형 패취
US20030232094A1 (en) * 2002-06-12 2003-12-18 Fuller Peter E. Composition and method for the treatment of skin irritations
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7939489B2 (en) * 2002-12-23 2011-05-10 Avon Products, Inc. Oil absorbent topical compositions and methods for using same
US20040175347A1 (en) * 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
US20060074097A1 (en) * 2003-03-04 2006-04-06 Bissett Donald L Regulation of mammalian keratinous tissue using hexamidine compositions
US20080076720A1 (en) * 2003-03-04 2008-03-27 Sancai Xie Personal care compositions having kinetin or zeatin
WO2004093866A1 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Process for preparing phenolic acid salts of gabapentin
WO2004093827A2 (en) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Phenolic acid salts of gabapentin in solid dosage forms and methods of use
EP1628656B1 (en) * 2003-03-25 2008-10-15 Kiel Laboratories, Inc. Gabapentin tannate in liquid and/or semi-solid dosage forms
US7285570B2 (en) * 2003-04-17 2007-10-23 The Procter & Gamble Company Compositions and methods for regulating mammalian keratinous tissue
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20050037979A1 (en) * 2003-06-05 2005-02-17 Ping Jeffrey H. Tannate compositions and methods of use
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
CA2536482C (en) * 2003-08-25 2012-07-24 Foamix Ltd. Penetrating pharmaceutical foam
CN100411692C (zh) * 2004-01-13 2008-08-20 北京康倍得医药技术开发有限公司 丙烯酸基粘合剂组合物及其药物组合物和透皮治疗系统
EP1713450B1 (en) 2004-01-30 2021-10-06 Corium, Inc. Rapidly dissolving film for delivery of an active agent
ZA200507017B (en) * 2004-02-04 2007-03-28 Foamix Ltd Cosmetic and pharmaceutical foam with solid matter
JP2005310310A (ja) * 2004-04-23 2005-11-04 Sanyo Electric Co Ltd トラッキングバランス調整装置
GB0410860D0 (en) * 2004-05-15 2004-06-16 Boots Healthcare Int Ltd Skincare composition
CN101039706A (zh) * 2004-08-05 2007-09-19 考里安国际公司 粘合剂组合物
US20060045858A1 (en) * 2004-08-26 2006-03-02 Fuller Peter E Composition and method for reducing harmful effects of ultraviolet radiation impinging on the skin
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
EP1811961A2 (en) * 2004-11-12 2007-08-01 Idea Ag Extended surface aggregates in the treatment of skin conditions
UY29449A1 (es) * 2005-03-30 2006-10-02 Astion Dev As Tratamiento de enfermedades dermatólogicas y del prurito.
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
EP2008642B1 (en) * 2005-10-26 2010-06-30 KPSS-Kao Professional Salon Services GmbH Hair conditioning composition comprising Polyquaternium-37
US20070128137A1 (en) * 2005-12-02 2007-06-07 Naohisa Yoshimi Water in oil emulsion compositions containing siloxane elastomers
US20070274932A1 (en) * 2006-05-15 2007-11-29 The Procter & Gamble Company Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers
US20070264210A1 (en) * 2006-05-15 2007-11-15 The Procter & Gamble Company Method of enhancing penetration of water-soluble actives
US20080038360A1 (en) * 2006-08-11 2008-02-14 Joseph Michael Zukowski Personal care composition
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2909279B1 (fr) * 2006-11-30 2014-06-13 Oreal Procede de peeling a base de microgel cationique
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
WO2008097851A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tetracycline compositions for topical administration
US20080188445A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
AR065378A1 (es) * 2007-02-16 2009-06-03 Procter & Gamble Articulo absorbente con locion que comprende un material de polipropilenglicol
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
US20090011035A1 (en) * 2007-07-03 2009-01-08 Joseph Michael Zukowski Personal care composition
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
KR20100065190A (ko) 2007-09-14 2010-06-15 닛토덴코 가부시키가이샤 약물 담체
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
PE20091156A1 (es) * 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8636988B2 (en) * 2008-01-31 2014-01-28 Doctor Essentials Composition for treatment of sunburned skin
US20090208443A1 (en) * 2008-02-19 2009-08-20 Conopco, Inc., D/B/A Unilever Cationic copolymer and starches formulated cosmetic compositions exhibiting radiance with soft focus
US7780954B2 (en) 2008-02-19 2010-08-24 Conopco, Inc. Glow and sunless tanning color enhancement by cationic copolymers
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
US8580282B2 (en) 2009-04-03 2013-11-12 St. Renatus, Llc Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
KR101736519B1 (ko) * 2009-09-30 2017-05-16 가부시키가이샤 시세이도 헤파라나제 활성 저해제 및 그것을 함유하는 주름 개선제 및 의약 조성물
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
AU2012245274B2 (en) * 2011-04-20 2016-09-22 Kao Usa, Inc. Self-tanning compositions having reduced Maillard reaction malodor
SE1300709A1 (sv) * 2013-11-14 2015-05-15 Lipidor Ab Komposition och metod för topikal behandling
JP2014015426A (ja) * 2012-07-10 2014-01-30 Wacker Asahikasei Silicone Co Ltd 入浴剤用シリコーンエマルジョン組成物
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20190083386A1 (en) * 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents
CN108467464A (zh) * 2018-04-02 2018-08-31 常熟理工学院 含壬二酸可见光固化水凝胶及其制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243470A (en) * 1969-01-31 1971-08-18 Unilever Ltd Hairdressings
US4009256A (en) * 1973-11-19 1977-02-22 National Starch And Chemical Corporation Novel shampoo composition containing a water-soluble cationic polymer
US3920810A (en) * 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4039501A (en) * 1975-05-30 1977-08-02 National Patent Development Corporation Plasticized hydrophilic polymers
US4355028A (en) * 1978-04-04 1982-10-19 Westwood Pharmaceuticals, Inc. Composition for treating acne vulgaris
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
AU8409582A (en) * 1981-06-15 1982-12-23 Alcon Laboratories, Inc. Urea and carboxyvinyl polymers gel compositions
US4540568A (en) * 1982-10-14 1985-09-10 Trager Seymour F Injectionable viscoelastic ophthalmic gel
GB8401206D0 (en) * 1984-01-17 1984-02-22 Allied Colloids Ltd Polymers and aqueous solutions
GB8414950D0 (en) * 1984-06-12 1984-07-18 Allied Colloids Ltd Cationic polyelectrolytes
GB8416453D0 (en) * 1984-06-28 1984-08-01 Allied Colloids Ltd Aqueous polymer dispersions
US5017367A (en) * 1984-10-01 1991-05-21 Stojkoski Radmila G Skin treatment preparation
US4608370A (en) * 1985-03-04 1986-08-26 Aronsohn Richard B Skin formulation
US4806345C1 (en) * 1985-11-21 2001-02-06 Johnson & Son Inc C Cross-linked cationic polymers for use in personal care products
GB8531118D0 (en) * 1985-12-18 1986-01-29 Allied Colloids Ltd Copolymers
US4704436A (en) * 1986-05-02 1987-11-03 Barabas Eugene S Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
GB8622797D0 (en) * 1986-09-22 1986-10-29 Allied Colloids Ltd Polymeric particles
ES2061508T3 (es) * 1986-10-01 1994-12-16 Allied Colloids Ltd Composiciones polimericas solubles en agua.
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.
US4929577A (en) * 1987-03-11 1990-05-29 Medi-Tech International Corporation Transparent wound dressings in sheet form
US4885161A (en) * 1987-03-11 1989-12-05 Medi-Tech International Corporation Wound dressings in gelled paste form
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
DE3736970C3 (de) * 1987-10-30 1996-08-01 Stockhausen Chem Fab Gmbh Wasserfreie Hautreinigungsmittel und ihre Verwendung
JPH07116035B2 (ja) * 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
JPH0749050B2 (ja) * 1988-01-18 1995-05-31 久光製薬株式会社 含水ゲル組成物
US5182105A (en) * 1988-10-25 1993-01-26 Kao Corporation Bathing composition
GB8909095D0 (en) * 1989-04-21 1989-06-07 Allied Colloids Ltd Thickened aqueous compositions
US5009969A (en) * 1989-05-26 1991-04-23 Hi-Tek Polymers, Inc. Dual action sunscreen composition
JPH0699285B2 (ja) * 1989-07-07 1994-12-07 花王株式会社 毛髪化粧料
GB2236760A (en) * 1989-10-11 1991-04-17 Inverness Corp Shaving gel
US5221530A (en) * 1991-06-24 1993-06-22 Helene Curtis, Inc. Mild conditioning shampoo with a high foam level containing an anionic surfactant-cationic acrylate/acrylamide copolymer conditioning agent
WO1993000882A1 (en) * 1991-07-08 1993-01-21 R.M. Walker Healthcare Products, Inc. Neutralizing rinse and improved method for chemically relaxing hair
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
DK0608353T3 (da) * 1991-10-16 1996-07-01 Richardson Vicks Inc Vandig, kosmetisk gel med lav pH-værdi og indeholdende ikke-ioniske polyacrylamidderivater
ES2114569T3 (es) * 1991-10-16 1998-06-01 Richardson Vicks Inc Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
US5232688A (en) * 1992-06-17 1993-08-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Self-tanner cosmetic compositions
AU5206499A (en) * 1998-06-27 2000-01-17 Lci/Smartpen, N.V. Apparatus and method for end-to-end authentication using biometric data

Also Published As

Publication number Publication date
FI950368A7 (fi) 1995-03-10
CN1072965C (zh) 2001-10-17
HK1006281A1 (en) 1999-02-19
NO950291D0 (no) 1995-01-26
MX9304530A (es) 1995-01-31
CA2141192C (en) 1999-02-02
DE69310518D1 (de) 1997-06-12
FI950368L (fi) 1995-03-10
DE69310518T2 (de) 1997-10-02
EP0652774A1 (en) 1995-05-17
ATE152630T1 (de) 1997-05-15
ES2101330T3 (es) 1997-07-01
KR950702436A (ko) 1995-07-29
JPH07509243A (ja) 1995-10-12
AU4673993A (en) 1994-02-14
EP0652774B1 (en) 1997-05-07
JP3567990B2 (ja) 2004-09-22
BR9306816A (pt) 1998-12-08
CN1091317A (zh) 1994-08-31
WO1994002176A1 (en) 1994-02-03
US5614178A (en) 1997-03-25
FI950368A0 (fi) 1995-01-27
CA2141192A1 (en) 1994-02-03

Similar Documents

Publication Publication Date Title
NO950291D0 (no) Farmasöytisk preparat inneholdende en tverrbundet kationisk polymer og en alkoksylert eter
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
DK278288A (da) Frigivelsessystem til laegemiddel ved anvendelse i mundhulen og en fremgangsmaade til fremstilling af dette frigivelsesystem
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
NZ507487A (en) 3,3-Diphenylpropylamine derivatives useful as anti muscarinic agents
FI970526A7 (fi) Estra-1,3,5(10)-trieenijohdannaiset, niiden valmistusmenetelmät sekä n äitä yhdisteitä sisältävät farmaseuttiset koostumukset
GB2334446A (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
MY114860A (en) Topical anti-inflammatory compositions containing piroxicam
MY120318A (en) Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses.
KR960705563A (ko) 펜벤다졸 제형(Fenbendazole formulations)
NO914077D0 (no) Galaktomannanderivater for omhylling eller innleiring av aktive bestanddeler i legemidler
PL308580A1 (en) Solid pharmaceutical composition for oral administration and method of preparing same
SE9403905D0 (sv) New formulations
JPS5750914A (en) Betamethasone external pharmaceutical
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
ATE108479T1 (de) Anethol enthaltende ethanolische zusammensetzungen.
NO20005486D0 (no) Stabil karbonilidblanding og fremgangsmÕte for fremstilling av denne
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
EP0817643A4 (en) SUBSTANCES AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
KR970032876A (ko) 간장질환 치료용 의약 조성물